产品
编 号：F096196
分子式：C24H28N6O5S
分子量：512.58
分子式：C24H28N6O5S
分子量：512.58
产品类型
规格
价格
是否有货
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
结构图
CAS No: 1254036-66-2
产品详情
生物活性：
GSK2292767 is a potent and selective inhibitor of PI3Kδ, with a pIC50 of 10.1. GSK2292767 showing greater than 500-fold selective over the other PI3K isoforms. GSK2292767 can be used for the research of respiratory disease.
体内研究：
GSK2292767 exhibits high clearance (50 mL/min/kg) in vivo and low oral bioavailability (F < 2%) in a rat PK study.GSK2292767 (0.01-1 μM) has no e?ect on QT interval, Tp?e, or QRS and no signi?cant risk of TdP arrhythmias in a rabbit cardiac ventricular wedge assay.GSK2292767 protects against eosinophil recruitment with an ED50 of 35 μg/kg in the brown Norway rat acute OVA model of Th2 driven in?ammation in the lungs of rats.
GSK2292767 is a potent and selective inhibitor of PI3Kδ, with a pIC50 of 10.1. GSK2292767 showing greater than 500-fold selective over the other PI3K isoforms. GSK2292767 can be used for the research of respiratory disease.
体内研究：
GSK2292767 exhibits high clearance (50 mL/min/kg) in vivo and low oral bioavailability (F < 2%) in a rat PK study.GSK2292767 (0.01-1 μM) has no e?ect on QT interval, Tp?e, or QRS and no signi?cant risk of TdP arrhythmias in a rabbit cardiac ventricular wedge assay.GSK2292767 protects against eosinophil recruitment with an ED50 of 35 μg/kg in the brown Norway rat acute OVA model of Th2 driven in?ammation in the lungs of rats.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备